We believe that any steps necessary to address the situation can be taken without changing the current robust statutory standards for clearance and approval of medical devices.
Editor's note · Context
Waxman cites a press release advocating for existing FDA standards.
Share
More from Henry Waxman
Thank you very much, Congressman Pallone, for recognizing me and for acknowledging the fact that I am the ranking member at the present time, but, of course, you will now take on that job very ably, I am sure, and both of us will follow in…
Our bill provides more resources to give them the additional enforcement authority and increases the fines for manufacturers that violate vehicle safety laws.
Although he made a number of very sensible recommendations, we heard at our hearing last September that the CSB chairman failed to adequately address these problems, and in fact, had created a dysfunctional work environment.
The $200 billion in the Waxman-Markey bill that passed the House of Representatives was turned down over here in the Senate.





